Skip to content

Ellen Gabler

Ellen Gabler is an investigative reporter for The New York Times. Since joining The Times in 2017, she has covered health and medical issues in addition to reporting on sexual harassment. Ms. Gabler previously worked at the Milwaukee Journal Sentinel as a reporter and deputy investigations editor.

 More

  1. Opioid Settlement Hinders Patients’ Access to a Wide Array of Drugs

    An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.

    By Christina Jewett and Ellen Gabler

     

  2. Amid Criticism, Elite Crime Teams Dwindled. Then Cities Brought Them Back.

    The Scorpion police team whose officers are charged in the death of Tyre Nichols has been disbanded. But Memphis wasn’t the only city to turn again to specialized teams to fight a new surge in crime.

    By Tim Arango and Ellen Gabler

     

  3. Are Your Patients Worried About the Polio Vaccine?

    We want to hear from you.

    By Ellen Gabler and Sheera Frenkel

     

  4. The Long Scourge of Lead Poisoning

    About 500,000 children in the United States have elevated levels of lead in their blood. But it is a problem with a deep past.

    By Ellen Gabler

     

  5. How 2 Industries Stymied Justice for Young Lead Paint Victims

    The U.S. insurance and real estate industries have waged a decades-long campaign to avoid liability in lead cases, helping to prolong an epidemic. The cost for millions of children has been incalculable.

    By Ellen Gabler

     

  6. Some experts worry that states’ plans to conduct their own vaccine reviews could sow confusion and doubt.

    This was featured in live coverage.

    By Ellen Gabler and Abby Goodnough

     

  7. States Vow Extra Scrutiny of Coronavirus Vaccine

    Special committees, mostly in Democratic-led states, will seek to reassure the public that an F.D.A.-approved vaccine is safe and effective amid doubts about the Trump administration’s virus response.

    By Ellen Gabler and Abby Goodnough

     

  8. Kodak C.E.O. Got Stock Options Day Before News of Loan Sent Stock Soaring

    The stock options suddenly were worth about $50 million — the latest instance of extraordinary good timing by corporate executives.

    By Jesse Drucker and Ellen Gabler

     

  9. The Doctor Behind the Disputed Covid Data

    Dr. Sapan Desai, who supplied the data for two prominent and later retracted studies, is said to have a history of cutting corners and misrepresenting information in pursuit of his ambitions.

    By Ellen Gabler and Roni Caryn Rabin

     

  10. CVS Fined for Prescription Errors and Poor Staffing at Pharmacies

    Regulators faulted four locations in Oklahoma, a rare action that followed complaints at drugstore chains across the country.

    By Ellen Gabler